1. Akera, T., Larsen, F.S., Brody, T.M.: The effect of ouabain on sodium-and potassium-activated adenosine triphosphatase from the hearts of several mammalian species. J. Pharmacol. Exp. Ther. 170, 17–26 (1969)
2. Akera, T.: Quantitative aspects of the interaction between ouabain and (Na ++K+)-activated ATPase in vitro. Biochim. Biophys. Acta (Amst.) 249, 53–62 (1971)
3. Akera, T., Brody, T.M.: Membrane adenosine triphosphatase: the effect of potassium on the formation and dissociation of the ouabain-enzyme complex. J. Pharmacol. Exp. Ther. 176, 545–557 (1971)
4. Akera, T., Baskin, S.I., Tobin, T., Brody, T.M.: Ouabain: temporal relationship between the inotropic effect and the in vitro binding to, and dissociation from, (Na + + K +)-activated ATPase. Naunyn-Schmiedeberg’s Arch. Pharmacol. 277, 151–162 (1973)
5. Akera, T., Bennett, R.T., Olgaard, M.K., Brody, T.M.: Cardiac Na+, K+-adenosine triphosphatase inhibition by ouabain and myocardial sodium: a computer simulation. J. Pharmacol. Exp. Ther. 199, 287–297 (1976)